...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Progress in drug research. >Chapter 9: Cultivation of Herbal Drugs, Biotechnology, and In Vitro Production of Secondary Metabolites, High-Value Medicinal Plants, Herbal Wealth, and Herbal Trade
【24h】

Chapter 9: Cultivation of Herbal Drugs, Biotechnology, and In Vitro Production of Secondary Metabolites, High-Value Medicinal Plants, Herbal Wealth, and Herbal Trade

机译：第9章：培养草药药物，生物技术和体外产量的次生代谢物，高价值药用植物，草药财富和草药贸易

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Medicinal plants are used directly as therapeutic agents in various traditional practices, and medicinal plants like Dioscorea deltoidea, Papaver som-niferum, Atropa belladonna, Rauvolfia serpentina, Hyoscyamus niger, Digitalis lanata, Datura metel, Digitalis purpurea, Pilocarpusa bonandi, Cinchona ledge-riana are contributing directly several prescribed medicinals. The ever-increasing trend in the use of medicinal herbs and herbal products in therapeutic purpose, research, and trade has created tremendous pressure on supply from their wild source. Under the circumstances of increasing demand, indiscriminate and over extraction from the wild, habitat destruction, etc., many of the naturally growing medicinal herbs are on the verge of extinction and thus unsustainability in the supply of medicinal plants from natural source. Systematic cultivation of medicinal herbs would be a viable alternative to overcome this unsustainability problem of medicinal plants from the wild source and cultivation offers opportunity to optimize yield and achieve a uniform, high-quality product. Several drugs like cardamom, cannabis, cinnamon, ginger, cinchona, opium, linseed, and fennel are now obtained almost exclusively from cultivation source. Benefits of cultivation of medicinal plants are widely viewed as a means for meeting current and future demands for large volume production of plant-based drugs; cultivation can reduce growing pressures on wild medicinal plants and ensure pure and smooth supply; means of earning livelihood, etc. The WHO has published wide-spectrum guidelines for good agricultural and collection practices for sustainable production of raw material of quality and standardized herbal ingredients to ensure quality of herbal medicines.
机译：药用植物直接用作各种传统实践中的治疗剂，以及Dioscorea Deltoidea等药用植物，罂粟属Som-Niferum，Atropa Belladonna，Rauvolfia Serpentina，Hyoscyamus尼日尔，Digitalis Lanata，Datura Metel，Digitalis Purpurea，Pilocarpusa Bonandi，Cinchona Medge-Riana正在促进几个规定的药物。在治疗目的，研究和贸易中使用药草和草药产品的不断增长的趋势为来自野生来源的供应产生了巨大的压力。在日益增长的需求情况下，不分青红皂白，从野外，栖息地破坏等中提取等，许多天然生长的药草都在灭绝的边缘，因此在自然来源的药用植物供应中不可持续。药材的系统培养将是一种可行的替代方案，以克服来自野生来源和栽培的药用植物的不可持续性问题，提供了优化产量和实现均匀，高质量的产品的机会。几乎完全来自培养来源，几乎可以从培养来源中获得几种类似豆蔻果实，大麻，肉桂，姜，池塘，鸦片，烟囱和茴香。培养药用植物的益处被广泛认为是满足植物型药物大量生产的当前和未来需求的手段;栽培可以减少野生药用植物的生长压力，并确保纯净和光滑的供应;赚取生计等手段等。世卫组织为良好的农业和收集实践发表了广泛的频谱准则，以便可持续生产质量和标准化草药成分的原材料，以确保草药的质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号